6-8
Oct
2026
CPHI Milan 2026
Fiera Milano, Italy
12J63

EirGenix Inc.

About EirGenix Inc.

EirGenix, Inc. is Taiwan’s largest biologics CDMO, providing comprehensive services from cell line and process development to GMP manufacturing and analytical testing. With globally recognized quality systems and regulatory approvals, we deliver reliable biomanufacturing solutions to global partners. Alongside our CDMO business, EirGenix is advancing its own biosimilar and ADC pipeline, focusing on antibody therapeutics for oncology and other diseases. At EirGenix, Clients’ Success is Our Priority, and we strive to make innovative, high-quality biologics accessible worldwide.

Certifications

Meet us at

  • CPHI Milan 2026

    Fiera Milano, Italy
    6 Oct 2026 - 8 Oct 2026
  • Country/Region:
    Taiwan
  • On CPHI since:
    2021
  • Certificates:
    3
  • Employees:
    250 - 499
Company types
Biopharmaceutical company
CMO/CDMO
Contract Service
Primary activities
Biopharmaceutical
Contact info
  • 101 Lane 169, Kangning Street, 221013, Taipei, Taipei City, Taiwan